Patent · US Active

Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1

US8883438B2 · kind B2 · utility

16Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2012
Grant dateNov 11, 2014
Priority date—
Expiry dateSep 14, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for treating and evaluating subjects having a neoactive mutation at residue 97 of IDH1 or 137 of IDH2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.